Press Release: Imstem Biotechnology : ImStem Announces First US Multiple Sclerosis Patient Has Been Dosed with its IMS001

FARMINGTON, Conn., Nov. 18, 2021 /PRNewswire/ -- ImStem Biotechnology, Inc. (Farmington CT), a biopharmaceutical company pioneering the development of human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC) through a proprietary method using a trophoblast intermediate...